From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver Pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and business process infrastructure for market access and therapy commercialization.
Solutions overview
IntegriChain delivers pharma’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the pharmaceutical industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Finance teams must be able to accurately forecast revenues while reconciling data coming from channel, patient, and operational divisions. Many pharmaceutical manufacturers do not have this alignment in place and as a result, often struggle with net-price transparency and reserve uncertainty during all phases of drug commercialization. Whether you are launching your first therapy or an established manufacturer looking to gain efficiencies in navigating an ever-changing commercial ecosystem, IntegriChain has the tools to help you manage a variety of challenges, including:
Having worked with hundreds of organizations to address these challenges, IntegriChain has established world-class, curated data, industry best practices, and benchmarks that financial professionals in the pharmaceutical industry can easily leverage via SaaS or as a managed service.
Manage audit and regulatory compliance, net-price of products, and model the potential impact of price changes on government pricing, Medicaid rebates, and gross-to-net processes.
Learn More
Leverage benchmark analogs for alike products, create market assessment on new strategies, and use SaaS automation tools for hyper-efficient financial planning and analysis operations.
Empower your FP&A team to take a more proactive, innovative approach to running the business by having all the critical payer, channel, and patient data on a common platform, seamlessly feeding their automated GTN processes.
Streamline pharma market access and therapy commercialization by quickly transforming patient, payer, complex transaction, and channel data into actionable insights through a single, unified platform